The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2024

Filed:

Mar. 15, 2020
Applicant:

Nutech Ventures, Lincoln, NE (US);

Inventors:

Mohammed Alwatban, Riyadh, SA;

Gregory R. Bashford, Lincoln, NE (US);

Assignee:

NUtech Ventures, Lincoln, NE (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/0285 (2006.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/021 (2006.01); A61B 5/08 (2006.01); A61B 5/087 (2006.01); C07K 16/28 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/0285 (2013.01); A61B 5/0205 (2013.01); A61B 5/02133 (2013.01); A61B 5/082 (2013.01); A61B 5/087 (2013.01); A61B 5/4088 (2013.01); A61B 5/4836 (2013.01); C07K 16/28 (2013.01); A61K 38/00 (2013.01);
Abstract

Provided here are methods of detecting compromised cerebrovascular reactivity in a subject and treating such subject. The method includes acquiring transcranial Doppler signals and cardiac measurements from the subject following a breath-hold maneuver and recording a test set of CBFV measurements. A breath-hold acceleration index is calculated based on a linear regression correlation of temporal variations of the mean velocity across all cardiac cycles during the breath-hold maneuver. The presence of compromised cerebrovascular reactivity in the subject is detected in response to variations in the breath-hold acceleration index of the subject as compared to a healthy individual performing breath-hold maneuver under similar conditions. If the subject has compromised cerebrovascular reactivity, a therapeutically effective compound is administered to the subject along with provision of behavioral modification regimen.


Find Patent Forward Citations

Loading…